Published in Ann Thorac Surg on April 01, 1994
Biopsy-induced tricuspid regurgitation: anatomic considerations. Ann Thorac Surg (1994) 1.38
Current status of endomyocardial biopsy. Mayo Clin Proc (2011) 1.20
Endomyocardial biopsy and selective coronary angiography are low-risk procedures in pediatric heart transplant recipients: results of a multicenter experience. J Heart Lung Transplant (2011) 1.06
Canadian Cardiovascular Society Consensus Conference guidelines on heart failure, update 2009: diagnosis and management of right-sided heart failure, myocarditis, device therapy and recent important clinical trials. Can J Cardiol (2009) 1.04
Cardiovascular magnetic resonance in the diagnosis of acute heart transplant rejection: a review. J Cardiovasc Magn Reson (2009) 1.02
Tricuspid valve regurgitation after orthotopic heart transplantation: prevalence and etiology. J Transplant (2012) 0.80
Complication rate of transfemoral endomyocardial biopsy with fluoroscopic and two-dimensional echocardiographic guidance: a 10-year experience of 228 consecutive procedures. J Korean Med Sci (2013) 0.78
Hazards of postoperative atrial arrhythmias. Ann Thorac Surg (1993) 4.98
The major genetic defect responsible for the polymorphism of S-mephenytoin metabolism in humans. J Biol Chem (1994) 3.75
Identification of a new genetic defect responsible for the polymorphism of (S)-mephenytoin metabolism in Japanese. Mol Pharmacol (1994) 3.05
The role of the CYP2C9-Leu359 allelic variant in the tolbutamide polymorphism. Pharmacogenetics (1996) 3.02
Influence of CYP2C9 and VKORC1 1173C/T genotype on the risk of hemorrhagic complications in African-American and European-American patients on warfarin. Clin Pharmacol Ther (2007) 2.54
Effect of reperfusion on biventricular function and survival after right ventricular infarction. N Engl J Med (1998) 2.12
Mechanism underlying mechanical dysfunction in the border zone of left ventricular aneurysm: a finite element model study. Ann Thorac Surg (2001) 1.94
Dityrosine, a specific marker of oxidation, is synthesized by the myeloperoxidase-hydrogen peroxide system of human neutrophils and macrophages. J Biol Chem (1993) 1.86
Polymorphisms in human CYP2C8 decrease metabolism of the anticancer drug paclitaxel and arachidonic acid. Pharmacogenetics (2001) 1.83
Guidelines for credentialing and granting privileges for endoscopic ultrasound. Gastrointest Endosc (2001) 1.81
Tyrosyl radical generated by myeloperoxidase catalyzes the oxidative cross-linking of proteins. J Clin Invest (1993) 1.79
Spline surface interpolation for calculating 3-D ventricular strains from MRI tissue tagging. Am J Physiol (1996) 1.75
Reexploration for bleeding is a risk factor for adverse outcomes after cardiac operations. J Thorac Cardiovasc Surg (1996) 1.73
Options for repair of a bicuspid aortic valve and ascending aortic aneurysm. Ann Thorac Surg (2000) 1.69
Human nonsyndromic hereditary deafness DFNA17 is due to a mutation in nonmuscle myosin MYH9. Am J Hum Genet (2000) 1.68
Surgical management of temporomandibular joint ankylosis in the pediatric population. Plast Reconstr Surg (1993) 1.60
Smallpox vaccination reactions, prophylaxis, and therapy of complications. Pediatrics (1975) 1.55
Identification of a null allele of CYP2C9 in an African-American exhibiting toxicity to phenytoin. Pharmacogenetics (2001) 1.53
Internal mammary artery grafts: the shortest route to the coronary arteries. Ann Thorac Surg (1989) 1.53
Site specific recombination involved in the generation of small plasmids. Mol Gen Genet (1978) 1.52
Previous coronary artery bypass grafting is not a risk factor for aortic valve replacement. Ann Thorac Surg (1997) 1.50
Ectopic ossification after median sternotomy. Ann Thorac Surg (1989) 1.46
Enhanced effect of liposome-encapsulated amikacin on Mycobacterium avium-M. intracellulare complex infection in beige mice. Antimicrob Agents Chemother (1988) 1.46
Elevations of CK-MB following pulmonary embolism. A manifestation of occult right ventricular infarction. Chest (1992) 1.44
Routine sternal closure using six overlapping figure-of-8 wires. Ann Thorac Surg (1997) 1.42
Efficacy of angioscopy in determining the effectiveness of intracoronary urokinase and TEC atherectomy thrombus removal from an occluded saphenous vein graft prior to stent implantation. Cathet Cardiovasc Diagn (1995) 1.39
Amodiaquine metabolism is impaired by common polymorphisms in CYP2C8: implications for malaria treatment in Africa. Clin Pharmacol Ther (2007) 1.39
Images in clinical medicine. Aortic intramural hematoma. N Engl J Med (1997) 1.38
Sex differences in the effects of alcohol on brain structure. Am J Psychiatry (2001) 1.34
The hydroxylation of omeprazole correlates with S-mephenytoin metabolism: a population study. Clin Pharmacol Ther (1995) 1.31
Cloning and expression of murine CYP2Cs and their ability to metabolize arachidonic acid. Arch Biochem Biophys (1998) 1.28
Metabolism of chlorpyrifos by human cytochrome P450 isoforms and human, mouse, and rat liver microsomes. Drug Metab Dispos (2001) 1.27
Identification of variants of CYP3A4 and characterization of their abilities to metabolize testosterone and chlorpyrifos. J Pharmacol Exp Ther (2001) 1.26
Brain CT changes in alcoholics: effects of age and alcohol consumption. Alcohol Clin Exp Res (1988) 1.24
Gene structure of CYP2C8 and extrahepatic distribution of the human CYP2Cs. J Biochem Mol Toxicol (1999) 1.23
Differences in the incidence of the CYP2C19 polymorphism affecting the S-mephenytoin phenotype in Chinese Han and Bai populations and identification of a new rare CYP2C19 mutant allele. J Pharmacol Exp Ther (1997) 1.22
A new genetic defect in human CYP2C19: mutation of the initiation codon is responsible for poor metabolism of S-mephenytoin. J Pharmacol Exp Ther (1998) 1.21
Obesity is not a risk factor for significant adverse outcomes after cardiac surgery. Circulation (1996) 1.20
Quality of life after aortic valve replacement at the age of >80 years. Circulation (2000) 1.20
Identification of the polymorphically expressed CYP2C19 and the wild-type CYP2C9-ILE359 allele as low-Km catalysts of cyclophosphamide and ifosfamide activation. Pharmacogenetics (1997) 1.18
Effect of acylation stimulating protein on the triacylglycerol synthetic pathway of human adipose tissue. Lipids (1991) 1.18
Cloning and expression of complementary DNAs for multiple members of the human cytochrome P450IIC subfamily. Biochemistry (1991) 1.18
Separation of pure polychlorinated biphenyl isomers into two types of inducers on the basis of induction of cytochrome P-450 or P-448. Chem Biol Interact (1977) 1.16
One-stage anterior cervical decompression and posterior stabilization. A study of one hundred patients with a minimum of two years of follow-up. J Bone Joint Surg Am (1995) 1.14
The role of transbronchial lung biopsy in the treatment of lung transplant recipients. An analysis of 200 consecutive procedures. Chest (1992) 1.14
Genetic analysis of the S-mephenytoin polymorphism in a Chinese population. Clin Pharmacol Ther (1995) 1.13
Comparative studies on the catalytic roles of cytochrome P450 2C9 and its Cys- and Leu-variants in the oxidation of warfarin, flurbiprofen, and diclofenac by human liver microsomes. Biochem Pharmacol (1998) 1.13
Histone H3K4 trimethylation by MLL3 as part of ASCOM complex is critical for NR activation of bile acid transporter genes and is downregulated in cholestasis. Am J Physiol Gastrointest Liver Physiol (2011) 1.12
Cochlear gene delivery through an intact round window membrane in mouse. Hum Gene Ther (2001) 1.12
The Washington University-Barnes Hospital experience with lung transplantation. Washington University Lung Transplantation Group. JAMA (1991) 1.12
Ticlopidine as a selective mechanism-based inhibitor of human cytochrome P450 2C19. Biochemistry (2001) 1.11
Splicing defects in the COL3A1 gene: marked preference for 5' (donor) spice-site mutations in patients with exon-skipping mutations and Ehlers-Danlos syndrome type IV. Am J Hum Genet (1997) 1.10
Fusion of liposomes containing a novel cationic lipid, N-[2,3-(dioleyloxy)propyl]-N,N,N-trimethylammonium: induction by multivalent anions and asymmetric fusion with acidic phospholipid vesicles. Biochemistry (1989) 1.09
Toothpick impaction with localized sigmoid perforation: successful colonoscopic management. Gastrointest Endosc (1999) 1.09
An additional defective allele, CYP2C19*5, contributes to the S-mephenytoin poor metabolizer phenotype in Caucasians. Pharmacogenetics (1998) 1.09
Identification of the human P450 enzymes involved in lansoprazole metabolism. J Pharmacol Exp Ther (1996) 1.08
Correlation of human cytochrome P4502C substrate specificities with primary structure: warfarin as a probe. Mol Pharmacol (1993) 1.08
The structure-activity relationships of halogenated biphenyls as enzyme inducers. Ann N Y Acad Sci (1979) 1.08
P300 reduction and prolongation with illness duration in schizophrenia. Biol Psychiatry (2000) 1.08
Pharmacokinetics of chlorpheniramine, phenytoin, glipizide and nifedipine in an individual homozygous for the CYP2C9*3 allele. Pharmacogenetics (1999) 1.08
The role of right ventricular systolic dysfunction and elevated intrapericardial pressure in the genesis of low output in experimental right ventricular infarction. Circulation (1982) 1.08
The evolution of single lung transplantation for emphysema. The Washington University Lung Transplant Group. J Thorac Cardiovasc Surg (1991) 1.06
A novel transversion in the intron 5 donor splice junction of CYP2C19 and a sequence polymorphism in exon 3 contribute to the poor metabolizer phenotype for the anticonvulsant drug S-mephenytoin. J Pharmacol Exp Ther (1999) 1.05
Revascularization after acute myocardial infarction. Ann Thorac Surg (1995) 1.04
Bioresorbable fixation for congenital pediatric craniofacial surgery: a 2-year follow-up. Pediatr Neurosurg (2000) 1.03
TRAM flap breast reconstruction and contralateral reduction or mastopexy. Plast Reconstr Surg (1993) 1.03
Identification of new human CYP2C19 alleles (CYP2C19*6 and CYP2C19*2B) in a Caucasian poor metabolizer of mephenytoin. J Pharmacol Exp Ther (1998) 1.03
Dose-response relationships for chronic exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin in a rat tumor promotion model: quantification and immunolocalization of CYP1A1 and CYP1A2 in the liver. Cancer Res (1992) 1.02
Experimental hepatic porphyria induced by polychlorinated biphenyls. Toxicol Appl Pharmacol (1974) 1.02
Incidence and angiographic predictors of side branch occlusion following high-pressure intracoronary stenting. Am J Cardiol (1997) 1.02
Influence of CYP2C9 and VKORC1 on warfarin response during initiation of therapy. Blood Cells Mol Dis (2009) 1.02
Identification and localization of five CYP2Cs in murine extrahepatic tissues and their metabolism of arachidonic acid to regio- and stereoselective products. J Pharmacol Exp Ther (2001) 1.01
2,3,7,8-Tetrachlorodibenzofuran in a commercially available 99% pure polychlorinated biphenyl isomer identified as the inducer of hepatic cytochrome P-448 and aryl hydrocarbon hydroxylase in the rat. Drug Metab Dispos (1978) 1.01
Expression of CYP1A1 and CYP1A2 genes in human liver. Pharmacogenetics (1993) 1.01
Pseudo Sister Mary Joseph's nodule. Am J Gastroenterol (1999) 1.00
Human CYP2C19 is a major omeprazole 5-hydroxylase, as demonstrated with recombinant cytochrome P450 enzymes. Drug Metab Dispos (1996) 1.00
Does the extent of proximal or distal resection influence outcome for type A dissections? Ann Thorac Surg (2001) 0.99
Complete hydatidiform mole with a coexistent healthy, viable fetus near term: a case report. J Reprod Med (1996) 0.99
Ribose-enhanced myocardial recovery following ischemia in the isolated working rat heart. J Thorac Cardiovasc Surg (1982) 0.97
Volume loading improves low cardiac output in experimental right ventricular infarction. J Am Coll Cardiol (1983) 0.97
Single lung transplantation for pulmonary hypertension. Single institution experience in 34 patients. Circulation (1995) 0.97
Toxicological assessment of hexachlorobiphenyl isomers and 2,3,7,8,-tetrachlorodibenzofuran in chicks. II. Effects on drug metabolism and porphyrin accumulation. Toxicol Appl Pharmacol (1976) 0.96
Mechanical dysfunction in the border zone of an ovine model of left ventricular aneurysm. Ann Thorac Surg (1995) 0.96
Chemotherapeutic potential of free and liposome encapsulated streptomycin against experimental Mycobacterium avium complex infections in beige mice. J Antimicrob Chemother (1991) 0.96
Differential induction of two 2,3,7,8-tetrachlorodibenzo-p-dioxin-inducible forms of cytochrome P-450 in extrahepatic versus hepatic tissues. Mol Pharmacol (1984) 0.96
A multifamily study on the relationship between CYP2C19 genotype and s-mephenytoin oxidation phenotype. Pharmacogenetics (1995) 0.96
Human CYP2C-mediated stereoselective phenytoin hydroxylation in Japanese: difference in chiral preference of CYP2C9 and CYP2C19. Biochem Pharmacol (1999) 0.95
Intraaortic balloon counterpulsation: patterns of usage and outcome in cardiac surgery patients. Ann Thorac Surg (1992) 0.95
Costs and outcomes of patients admitted with chest pain and essentially normal electrocardiograms. Clin Cardiol (1998) 0.94
Assessment of denaturing high-performance liquid chromatography (DHPLC) in screening for mutations in connexin 26 (GJB2). Hum Mutat (2001) 0.94
Reduction of sternal infection by application of topical vancomycin. J Thorac Cardiovasc Surg (1989) 0.93
The role of endoscopy in dyspepsia. Gastrointest Endosc (2001) 0.93
Comparative effect of isotretinoin and etretinate on acne and sebaceous gland secretion. J Am Acad Dermatol (1982) 0.93
Limulus amebocyte lysate test in neonates. Am J Clin Pathol (1976) 0.93
Myocardial material property determination in the in vivo heart using magnetic resonance imaging. Int J Card Imaging (1996) 0.93
Pulmonary transplantation. Ann Surg (1995) 0.93
Natural-Y Même polyurethane versus smooth silicone: analysis of the soft-tissue interaction from 3 days to 1 year in the rat animal model. Plast Reconstr Surg (1990) 0.93
Inaccuracy of cardiac output by thermodilution during acute tricuspid regurgitation. Ann Thorac Surg (1992) 0.92
Epicardial suction: a new approach to mechanical testing of the passive ventricular wall. J Biomech Eng (2000) 0.92